Properties and Modeling of GWAS when Complex Disease Risk Is Due to Non-Complementing, Deleterious Mutations in Genes of Large Effect
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Current genome-wide association studies (GWAS) have high power to detect intermediate frequency SNPs making modest contributions to complex disease, but they are underpowered to detect rare alleles of large effect (RALE). This has led to speculation that the bulk of variation for most complex diseases is due to RALE. One concern with existing models of RALE is that they do not make explicit assumptions about the evolution of a phenotype and its molecular basis. Rather, much of the existing literature relies on arbitrary mapping of phenotypes onto genotypes obtained either from standard population-genetic simulation tools or from non-genetic models. We introduce a novel simulation of a 100-kilobase gene region, based on the standard definition of a gene, in which mutations are unconditionally deleterious, are continuously arising, have partially recessive and non-complementing effects on phenotype (analogous to what is widely observed for most Mendelian disorders), and are interspersed with neutral markers that can be genotyped. Genes evolving according to this model exhibit a characteristic GWAS signature consisting of an excess of marginally significant markers. Existing tests for an excess burden of rare alleles in cases have low power while a simple new statistic has high power to identify disease genes evolving under our model. The structure of linkage disequilibrium between causative mutations and significantly associated markers under our model differs fundamentally from that seen when rare causative markers are assumed to be neutral. Rather than tagging single haplotypes bearing a large number of rare causative alleles, we find that significant SNPs in a GWAS tend to tag single causative mutations of small effect relative to other mutations in the same gene. Our results emphasize the importance of evaluating the power to detect associations under models that are genetically and evolutionarily motivated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, B., & Leal, S. M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.06.024 · Cited by 1,527 · cited 8×
“The power of existing tests for RALE We applied Madsen and Browning’s rank-sum test [16], Li and Leal’s multiple marker test [15], and the software package SKAT [21,29,30] to our simulated data.”
BackgroundMethodResultInfluentialA Mathematical Theory of Natural and Artificial Selection, Part V: Selection and Mutation
Haldane, J. B. S. (1927) · Mathematical Proceedings of the Cambridge Philosophical Society · doi:10.1017/s0305004100015644 · Cited by 1,326 · cited 3×
“Our results suggest a different interpretation of missing heritability, one which is consistent with standard populationgenetic predictions of an inverse relationship between frequency and the effect size of a deleterious mutation [11,12,23].”
BackgroundResultInfluentialAre Rare Variants Responsible for Susceptibility to Complex Diseases?
Pritchard, J. K. (2001) · The American Journal of Human Genetics · doi:10.1086/321272 · Cited by 1,197 · cited 14×
“Our results suggest a different interpretation of missing heritability, one which is consistent with standard populationgenetic predictions of an inverse relationship between frequency and the effect size of a deleterious mutation [11,12,23].”
BackgroundResultInfluentialA Groupwise Association Test for Rare Mutations Using a Weighted Sum Statistic
Madsen, B. E., & Browning, S. R. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000384 · Cited by 1,113
Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol
Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R., & Hobbs, H. H. (2004) · Science · doi:10.1126/science.1099870 · Cited by 1,108 · cited 1×
“for a variety of diseases (HDL cholesterol levels [3], susceptibility to colorectal adenomas [4], LDL cholesterol levels [5], triglyceride levels [6], folate metabolism [7], and hypertriglyceridemia susceptibility [8].”
BackgroundRare Variants Create Synthetic Genome-Wide Associations
Dickson, S. P., Wang, K., Krantz, I., Hakonarson, H., & Goldstein, D. B. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000294 · Cited by 857 · cited 9×
“This observed relationship between common SNPs significant in a GWAS and causative alleles is inconsistent with the claim of recently published work that introduced the idea of a synthetic association resulting from a common marker tagging a haplotype(s) harboring an excess of rare causative mutations [19,38].”
BackgroundMethodResultInfluentialPooled Association Tests for Rare Variants in Exon-Resequencing Studies
Price, A. L., Kryukov, G. V., de Bakker, P. I. W., Purcell, S. M., Staples, J., Wei, L.-J., & Sunyaev, S. R. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.04.005 · Cited by 755 · cited 2×
“The simulation output is then used to map genotype to phenotype using either an arbitrary model [24,25] or an explicit quantitative genetic model [23].”
MethodResultInfluentialMutations affecting fitness in Drosophila populations.
Simmons, M. J., & Crow, J. F. (1977) · Annual Review of Genetics · doi:10.1146/annurev.ge.11.120177.000405 · Cited by 584
A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein Cholesterol
Kotowski, I. K., Pertsemlidis, A., Luke, A., Cooper, R. S., Vega, G. L., Cohen, J. C., & Hobbs, H. H. (2006) · The American Journal of Human Genetics · doi:10.1086/500615 · Cited by 517 · cited 1×
“for a variety of diseases (HDL cholesterol levels [3], susceptibility to colorectal adenomas [4], LDL cholesterol levels [5], triglyceride levels [6], folate metabolism [7], and hypertriglyceridemia susceptibility [8].”
BackgroundRomeo, S., Pennacchio, L. A., Fu, Y., Boerwinkle, E., Tybjaerg-Hansen, A., Hobbs, H. H., & Cohen, J. C. (2007) · Nature Genetics · doi:10.1038/ng1984 · Cited by 511 · cited 1×
“for a variety of diseases (HDL cholesterol levels [3], susceptibility to colorectal adenomas [4], LDL cholesterol levels [5], triglyceride levels [6], folate metabolism [7], and hypertriglyceridemia susceptibility [8].”
Background
Cited by
The deleterious mutation load is insensitive to recent population history.
Simons, Y. B., Turchin, M. C., Pritchard, J. K., & Sella, G. (2014) · Nature Genetics · doi:10.1038/ng.2896 · Cited by 279
“The answers to these questions are of practical importance because different study designs may be needed to identify rare variants 13, 15, 16, 23 .”
Extreme Polygenicity of Complex Traits Is Explained by Negative Selection
O'Connor, L. J., Schoech, A. P., Hormozdiari, F., Gazal, S., Patterson, N., & Price, A. L. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.07.003 · Cited by 268
Structural variants exhibit widespread allelic heterogeneity and shape variation in complex traits
Chakraborty, M., Emerson, J. J., Macdonald, S. J., & Long, A. D. (2019) · Nature Communications · doi:10.1038/s41467-019-12884-1 · Cited by 186
Self-citationExcess of genomic defects in a woolly mammoth on Wrangel island
Rogers, R. L., & Slatkin, M. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006601 · Cited by 134
Genome-wide association studies of suicidal behaviors: a review
Sokolowski, M., Wasserman, J., & Wasserman, D. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.08.006 · Cited by 48
Sokolowski, M., Wasserman, J., & Wasserman, D. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32694 · Cited by 30
“The ESM tests if the overall SNP pvalues across a gene are lower than expected by chance (Thornton et al., 2013) and was used here to evaluate each gene as a selfcontained hypothesis (see Supporting Information text and Figures S3 and S4).”
Method
Metadata
- Authors
- Thornton, K. R., Foran, A. J., & Long, A. D.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-02-21
- Volume
- 9
- Issue
- 2
- Pages
- e1003258
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W1997528802
- Cited by
- 70
- References
- 12
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.